Literature DB >> 1325232

Long term follow up of women with borderline cervical smear test results: effects of age and viral infection on progression to high grade dyskaryosis.

L Hirschowitz1, A E Raffle, E F Mackenzie, A O Hughes.   

Abstract

OBJECTIVE: To follow up and assess the significance of borderline change in cervical smears.
DESIGN: Retrospective study of women undergoing routine cervical cytological screening in 1981.
SETTING: Avon Cervical Screening Programme, covering 250,000 women in Bristol and Weston super Mare.
SUBJECTS: 437 women showing borderline cervical changes in 1981 and 437 age matched controls with normal results in 1981. MAIN OUTCOME MEASURES: Cytological progression to high grade dyskaryosis (cervical intraepithelial neoplasia grade III or invasive carcinoma).
RESULTS: During follow up ranging from 13 to 106 months 98 of the 437 women (22.4%) with borderline cytological changes on routine cervical cytology screening had a subsequent smear test showing high grade dyskaryosis compared with three of the 437 women (0.9%) in the control group. The risk of progression was greater in women aged 20 to 39 than in those aged 40 and over. Human papillomavirus infection had initially been diagnosed cytologically in 101 of the 437 (23%) women with borderline results. Significantly fewer of these women developed high grade dyskaryosis (13/98 (13%) v 88/339 (26%), p less than 0.05).
CONCLUSIONS: Women with borderline smear test results are at increased risk of developing high grade dyskaryosis, particularly if the borderline changes occur without cytological features of human papillomavirus infection. Progression occurs within three years in 50% of cases, although a linearly increasing risk was sustained over the nine years of follow up and was greatest in women aged 20 to 39. Careful follow up of these women is indicated.

Entities:  

Mesh:

Year:  1992        PMID: 1325232      PMCID: PMC1881787          DOI: 10.1136/bmj.304.6836.1209

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Viruses and cervical cancer.

Authors:  A Singer; D Jenkins
Journal:  BMJ       Date:  1991-02-02

2.  Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer.

Authors:  G B Kristensen; K D Skyggebjerg; B Hølund; K Holm; M K Hansen
Journal:  Acta Cytol       Date:  1991 Jan-Feb       Impact factor: 2.319

3.  High rate of human papillomavirus type 16 infection in cytologically normal cervices.

Authors:  J A Tidy; G C Parry; P Ward; D V Coleman; J Peto; A D Malcolm; P J Farrell
Journal:  Lancet       Date:  1989-02-25       Impact factor: 79.321

Review 4.  Does HPV cause cervical cancer?

Authors:  H C Kitchener
Journal:  Br J Obstet Gynaecol       Date:  1988-11

5.  Cervical conization: an experience with 400 patients.

Authors:  R M Davis; J K Cooke; R F Kirk
Journal:  Obstet Gynecol       Date:  1972-07       Impact factor: 7.661

6.  Should patients with mild atypia in a cervical smear be referred for colposcopy?

Authors:  W P Soutter; S Wisdom; A K Brough; J M Monaghan
Journal:  Br J Obstet Gynaecol       Date:  1986-01

7.  Management of women with abnormal cervical smears: supplement to terminology in gynaecological cytopathology.

Authors:  D M Evans; E A Hudson; C L Brown; M M Boddington; H E Hughes; E F Mackenzie
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

8.  Histological correlates of clinically occult human papillomavirus infection of the uterine cervix.

Authors:  G J Nuovo; M A Nuovo; S Cottral; S Gordon; S J Silverstein; C P Crum
Journal:  Am J Surg Pathol       Date:  1988-03       Impact factor: 6.394

9.  Risk of cervical cancer associated with mild dyskaryosis.

Authors:  J H Robertson; B E Woodend; E H Crozier; J Hutchinson
Journal:  BMJ       Date:  1988-07-02

10.  Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study.

Authors:  M J Campion; D J McCance; J Cuzick; A Singer
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

View more
  11 in total

1.  Progression of borderline abnormalities on cervical smear testing.

Authors:  M A Ratcliffe; A A Dawson; G Flannelly
Journal:  BMJ       Date:  1992-06-27

2.  Progression of borderline abnormalities on cervical smear testing.

Authors:  K A Hussein; D M Parham
Journal:  BMJ       Date:  1992-06-27

3.  Progression of borderline abnormalities on cervical smear testing.

Authors:  J Hopwood
Journal:  BMJ       Date:  1992-06-27

4.  Borderline nuclear changes in cervical smears: guidelines on their recognition and management. National Coordinating Network (National Cervical Screening Programme), British Society for clinical Cytology, and Royal College of Pathologists' Working Party.

Authors: 
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

5.  Management of cervical dyskaryosis.

Authors:  W P Soutter
Journal:  BMJ       Date:  1994-09-17

6.  HPV testing in patients with low grade cervical cytological abnormalities: a follow up study.

Authors:  C S Herrington; M F Evans; F M Charnock; W Gray; J O'D McGee
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

7.  Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up.

Authors:  W J Melchers; J M Bakkers; J Wang; P C de Wilde; H Boonstra; W G Quint; A G Hanselaar
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

8.  Follow up of women with borderline cervical smears as defined by national guidelines.

Authors:  M K Heatley
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

9.  The borderline cervical smear: colposcopic and biopsy outcome.

Authors:  A al-Nafussi; G Rebello; R al-Yusif; E McGoogan
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

10.  Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically.

Authors:  W P Soutter; A Fletcher
Journal:  BMJ       Date:  1994-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.